Related Experiment Video
Updated: Jun 12, 2026

06:38
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma
Paul J Kelly1, Stephanie E Weiss, David J Sher
1Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Abstract
No abstract available in PubMed .

